U.S. Lipid POCT Market to 2032
Overview
The U.S. Lipid POCT Market is expected to reach a 507.21 USD Million by 2032 and is projected to grow at a CAGR of 7.97% from 2025 to 2032.
Revenue, 2024 (USD Million)
343.49
Forecast, 2032 (USD Million)
507.21
CAGR, 2024 - 2032
7.97%
Report Coverage
U.S.
U.S. Lipid POCT Market 2018-2032 USD Million
U.S. Lipid POCT Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 343.49 USD Million
- Projected Market Size (2032): 507.21 USD Million
- CAGR (2025-2032): 7.97%
Key Findings of U.S. Lipid POCT Market
- The U.S. Lipid POCT Market was valued at 343.49 USD Million in 2024.
- The U.S. Lipid POCT Market is likely to grow at a CAGR of 7.97% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Prescription-Based Testing in Mode Segment accounted for the largest share of the market with a revenue of 278.90 USD Million
- The fastest growing segment Alere Cholestech LDX in Brand Segment grew Fastest with a CAGR of 11.38% during the forecast period from 2024 to 2032.
U.S. Lipid POCT Market Scope
U.S. Lipid POCT Market Segmentation & Scope
Type
- Consumables And Kits
- Instruments
Platform
- Microfluidics
- Dipsticks
- Immunoassays
- Molecular Diagnostics
- Lateral Flow Assays /Immunochromatography Tests
End User
- Other End Users
- Research Laboratories
- Home Care
- Professional Diagnostic Centers
- Hospitals
Distribution Channel
- Retail Sales
- Direct Tenders
Brand
- PTS Cardiochek
- Alere Afinion
- Alere Cholestech LDX
- Others
- Roche Cobas B 101
- Roche Reflotron
Application
- Others
- Tangier Disease
- Familial Hypercholesterolemia
- Hyperlipoproteinemia
- Hypertriglyceridemia
- Hyperlipidemia
Mode
- OTC-Based Testing
- Prescription-Based Testing
U.S. Lipid POCT Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 343.49 USD Million |
| Market Value in 2032 | 507.21 USD Million |
| CAGR (2025-2032) | 7.97% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Type,Platform,End User,Distribution Channel,Brand,Application,Mode |
Regional Insights:
-
Leading Market (2024-2032): U.S., leading in terms of revenue 343.49 USD Million in 2024
- Key Country: U.S., leading in terms of revenue with value of 343.49 USD Million in 2024.
Segments and Scope
-
U.S. Lipid POCT Market to 2032, By Type
- Instruments is the largest segment in U.S. Lipid POCT Market to 2032 with a revenue of 204.95 USD Million in the year 2024.
- Consumables And Kits is the Fastest growing segment in U.S. Lipid POCT Market to 2032 with a Growth rate of 7.05 % in forecast period 2025-2032.
-
U.S. Lipid POCT Market to 2032, By Platform
- Molecular Diagnostics is the largest segment in U.S. Lipid POCT Market to 2032 with a revenue of 108.52 USD Million in the year 2024.
- Molecular Diagnostics is the Fastest growing segment in U.S. Lipid POCT Market to 2032 with a Growth rate of 8.90 % in forecast period 2025-2032.
-
U.S. Lipid POCT Market to 2032, By End User
- Professional Diagnostic Centers is the largest segment in U.S. Lipid POCT Market to 2032 with a revenue of 108.52 USD Million in the year 2024.
- Professional Diagnostic Centers is the Fastest growing segment in U.S. Lipid POCT Market to 2032 with a Growth rate of 8.90 % in forecast period 2025-2032.
-
U.S. Lipid POCT Market to 2032, By Distribution Channel
- Direct Tenders is the largest segment in U.S. Lipid POCT Market to 2032 with a revenue of 210.84 USD Million in the year 2024.
- Retail Sales is the Fastest growing segment in U.S. Lipid POCT Market to 2032 with a Growth rate of 7.63 % in forecast period 2025-2032.
-
U.S. Lipid POCT Market to 2032, By Brand
- Roche Reflotron is the largest segment in U.S. Lipid POCT Market to 2032 with a revenue of 168.11 USD Million in the year 2024.
- Alere Cholestech LDX is the Fastest growing segment in U.S. Lipid POCT Market to 2032 with a Growth rate of 8.25 % in forecast period 2025-2032.
-
U.S. Lipid POCT Market to 2032, By Application
- Hyperlipidemia is the largest segment in U.S. Lipid POCT Market to 2032 with a revenue of 211.28 USD Million in the year 2024.
- Hypertriglyceridemia is the Fastest growing segment in U.S. Lipid POCT Market to 2032 with a Growth rate of 7.20 % in forecast period 2025-2032.
-
U.S. Lipid POCT Market to 2032, By Mode
- Prescription-Based Testing is the largest segment in U.S. Lipid POCT Market to 2032 with a revenue of 278.90 USD Million in the year 2024.
- OTC-Based Testing is the Fastest growing segment in U.S. Lipid POCT Market to 2032 with a Growth rate of 7.57 % in forecast period 2025-2032.
U.S. Lipid POCT Market Company Share Analysis
| Company Name |
|
||
| Quest Diagnostics Incorporated | |||
| Abbott | |||
| A. Menarini Diagnostics s.r.l | |||
| F. Hoffmann-La Roche Ltd. | |||
| Siemens Healthcare GmbH | |||
U.S. Lipid POCT Market Geographical Sales Distribution, 2018-2032 USD Million
U.S. Lipid POCT Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The U.S. Lipid POCT Market is segmented based on Segmentation Type,Platform,End User,Distribution Channel,Brand,Application,Mode.
U.S. Lipid POCT Market was valued at USD 343.49(Revenue in USD Million) in 2020.
U.S. Lipid POCT Market is projected to grow at a CAGR of 7.97% during the forecast period of 2024 to 2032.
The Prescription-Based Testing segment is expected to dominate the U.S. Lipid POCT Market, holding a largest market share of 278.90 USD Million in 2024
U.S. Lipid POCT Market Scope
U.S. Lipid POCT Market Segmentation & Scope
Type
- Consumables And Kits
- Instruments
Platform
- Microfluidics
- Dipsticks
- Immunoassays
- Molecular Diagnostics
- Lateral Flow Assays /Immunochromatography Tests
End User
- Other End Users
- Research Laboratories
- Home Care
- Professional Diagnostic Centers
- Hospitals
Distribution Channel
- Retail Sales
- Direct Tenders
Brand
- PTS Cardiochek
- Alere Afinion
- Alere Cholestech LDX
- Others
- Roche Cobas B 101
- Roche Reflotron
Application
- Others
- Tangier Disease
- Familial Hypercholesterolemia
- Hyperlipoproteinemia
- Hypertriglyceridemia
- Hyperlipidemia
Mode
- OTC-Based Testing
- Prescription-Based Testing
Frequently Asked Questions
The U.S. Lipid POCT Market is segmented based on Segmentation Type,Platform,End User,Distribution Channel,Brand,Application,Mode.
U.S. Lipid POCT Market was valued at USD 343.49(Revenue in USD Million) in 2020.
U.S. Lipid POCT Market is projected to grow at a CAGR of 7.97% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Lipid POCT Market for final year is USD 507.21 (USD Million).
U.S. Lipid POCT Market Company Profiling
Frequently Asked Questions
The U.S. Lipid POCT Market is segmented based on Segmentation Type,Platform,End User,Distribution Channel,Brand,Application,Mode.
U.S. Lipid POCT Market was valued at USD 343.49(Revenue in USD Million) in 2020.
U.S. Lipid POCT Market is projected to grow at a CAGR of 7.97% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Lipid POCT Market for final year is USD 507.21 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.